{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:11:49Z","timestamp":1791688309669,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-31322S"],"award-info":[{"award-number":["20-31322S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, LX22NPO5102"],"award-info":[{"award-number":["EXCELES, LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transgenic Res"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Proto-oncogene KRAS, GTPase (KRAS) is one of the most intensively studied oncogenes in cancer research. Although several mouse models allow for regulated expression of mutant KRAS, selective isolation and analysis of transforming or tumor cells that produce the KRAS oncogene remains a challenge. In our study, we present a knock-in model of oncogenic variant KRAS<jats:sup>G12D<\/jats:sup> that enables the \u201cactivation\u201d of KRAS<jats:sup>G12D<\/jats:sup> expression together with production of red fluorescent protein tdTomato. Both proteins are expressed from the endogenous <jats:italic>Kras<\/jats:italic> locus after recombination of a transcriptional stop box in the genomic DNA by the enzyme flippase (Flp). We have demonstrated the functionality of the allele termed <jats:italic>RedRas<\/jats:italic> (abbreviated <jats:italic>Kras<\/jats:italic><jats:sup><jats:italic>RR<\/jats:italic><\/jats:sup>) under in vitro conditions with mouse embryonic fibroblasts and organoids and in vivo in the lung and colon epithelium. After recombination with adenoviral vectors carrying the <jats:italic>Flp<\/jats:italic> gene, the <jats:italic>Kras<\/jats:italic><jats:sup><jats:italic>RR<\/jats:italic><\/jats:sup> allele itself triggers formation of lung adenomas. In the colon epithelium, it causes the progression of adenomas that are triggered by the loss of tumor suppressor adenomatous polyposis coli (APC). Importantly, cells in which recombination has successfully occurred can be visualized and isolated using the fluorescence emitted by tdTomato. Furthermore, we show that KRAS<jats:sup>G12D<\/jats:sup> production enables intestinal organoid growth independent of epidermal growth factor (EGF) signaling and that the KRAS<jats:sup>G12D<\/jats:sup> function is effectively suppressed by specific inhibitor MRTX1133.<\/jats:p>","DOI":"10.1007\/s11248-024-00429-2","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:32:29Z","timestamp":1736436749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells"],"prefix":"10.1007","volume":"34","author":[{"given":"Dusan","family":"Hrckulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Onhajzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Krausova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Stastna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitezslav","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Janeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Korinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"429_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ymeth.2003.11.006","volume":"33","author":"A Amalfitano","year":"2004","unstructured":"Amalfitano A (2004) Utilization of adenovirus vectors for multiple gene transfer applications. Methods 33:173\u2013178. https:\/\/doi.org\/10.1016\/j.ymeth.2003.11.006","journal-title":"Methods"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8:455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z","journal-title":"Signal Transduct Target Ther"},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/jcp.25890","volume":"233","author":"A Bahrami","year":"2018","unstructured":"Bahrami A et al (2018) Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. J Cell Physiol 233:2058\u20132066. https:\/\/doi.org\/10.1002\/jcp.25890","journal-title":"J Cell Physiol"},{"key":"429_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nbt0798-657","volume":"16","author":"F Buchholz","year":"1998","unstructured":"Buchholz F, Angrand PO, Stewart AF (1998) Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 16:657\u2013662. https:\/\/doi.org\/10.1038\/nbt0798-657","journal-title":"Nat Biotechnol"},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/ijc.23383","volume":"122","author":"SR Calcagno","year":"2008","unstructured":"Calcagno SR, Li S, Colon M, Kreinest PA, Thompson EA, Fields AP, Murray NR (2008) Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer 122:2462\u20132470. https:\/\/doi.org\/10.1002\/ijc.23383","journal-title":"Int J Cancer"},{"key":"429_CR6","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer Nature 487:330\u2013337. https:\/\/doi.org\/10.1038\/nature11252","DOI":"10.1038\/nature11252"},{"key":"429_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00428-024-03746-3","volume":"484","author":"PD Dunne","year":"2024","unstructured":"Dunne PD, Arends MJ (2024) Molecular pathological classification of colorectal cancer-an update. Virchows Arch 484:273\u2013285. https:\/\/doi.org\/10.1007\/s00428-024-03746-3","journal-title":"Virchows Arch"},{"key":"429_CR8","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage M, Dooley AL, Jacks T (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4:1064\u20131072. https:\/\/doi.org\/10.1038\/nprot.2009.95","journal-title":"Nat Protoc"},{"key":"429_CR9","doi-asserted-by":"publisher","unstructured":"Fakih MG et al. (2022) Sotorasib for previously treated colorectal cancers with KRAS(G12C) mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial Lancet Oncol 23:115\u2013124. https:\/\/doi.org\/10.1016\/S1470-2045(21)00605-7","DOI":"10.1016\/S1470-2045(21)00605-7"},{"key":"429_CR10","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1073\/pnas.93.20.10887","volume":"93","author":"R Feil","year":"1996","unstructured":"Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93:10887\u201310890. https:\/\/doi.org\/10.1073\/pnas.93.20.10887","journal-title":"Proc Natl Acad Sci USA"},{"key":"429_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.lungcan.2018.07.013","volume":"124","author":"I Ferrer","year":"2018","unstructured":"Ferrer I, Zugazagoitia J, Herbertz S, John W, Paz-Ares L, Schmid-Bindert G (2018) KRAS-mutant non-small cell lung cancer: from biology to therapy. Lung Cancer 124:53\u201364. https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.013","journal-title":"Lung Cancer"},{"key":"429_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.trecan.2017.08.006","volume":"3","author":"KM Haigis","year":"2017","unstructured":"Haigis KM (2017) KRAS alleles: the devil is in the detail. Trends Cancer 3:686\u2013697. https:\/\/doi.org\/10.1016\/j.trecan.2017.08.006","journal-title":"Trends Cancer"},{"key":"429_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.115","volume":"40","author":"KM Haigis","year":"2008","unstructured":"Haigis KM et al (2008) Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 40:600\u2013608. https:\/\/doi.org\/10.1038\/ng.115","journal-title":"Nat Genet"},{"key":"429_CR14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","volume":"28","author":"J Hallin","year":"2022","unstructured":"Hallin J et al (2022) Anti-tumor efficacy of a potent and selective non-covalent KRAS(G12D) inhibitor. Nat Med 28:2171\u20132182. https:\/\/doi.org\/10.1038\/s41591-022-02007-7","journal-title":"Nat Med"},{"key":"429_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"429_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1242\/jcs.182873","volume":"129","author":"GA Hobbs","year":"2016","unstructured":"Hobbs GA, Der CJ, Rossman KL (2016) RAS isoforms and mutations in cancer at a glance. J Cell Sci 129:1287\u20131292. https:\/\/doi.org\/10.1242\/jcs.182873","journal-title":"J Cell Sci"},{"key":"429_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/genes9090439","author":"D Hrckulak","year":"2018","unstructured":"Hrckulak D et al (2018) Wnt effector TCF4 is dispensable for wnt signaling in human cancer cells. Genes (Basel). https:\/\/doi.org\/10.3390\/genes9090439","journal-title":"Genes (Basel)"},{"key":"429_CR18","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson EL et al (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15:3243\u20133248. https:\/\/doi.org\/10.1101\/gad.943001","journal-title":"Genes Dev"},{"key":"429_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1541-7786.MCR-15-0033","volume":"13","author":"L Janeckova","year":"2015","unstructured":"Janeckova L et al (2015) HIC1 tumor suppressor loss potentiates TLR2\/NF-kappaB signaling and promotes tissue damage-associated tumorigenesis. Mol Cancer Res 13:1139\u20131148. https:\/\/doi.org\/10.1158\/1541-7786.MCR-15-0033","journal-title":"Mol Cancer Res"},{"key":"429_CR20","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1016\/j.febslet.2014.09.014","volume":"588","author":"P Kasparek","year":"2014","unstructured":"Kasparek P, Krausova M, Haneckova R, Kriz V, Zbodakova O, Korinek V, Sedlacek R (2014) Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett 588:3982\u20133988. https:\/\/doi.org\/10.1016\/j.febslet.2014.09.014","journal-title":"FEBS Lett"},{"key":"429_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","volume":"619","author":"D Kim","year":"2023","unstructured":"Kim D et al (2023) Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature 619:160\u2013166. https:\/\/doi.org\/10.1038\/s41586-023-06123-3","journal-title":"Nature"},{"key":"429_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","volume":"290","author":"MG Kris","year":"2003","unstructured":"Kris MG et al (2003) Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 290:2149\u20132158. https:\/\/doi.org\/10.1001\/jama.290.16.2149","journal-title":"JAMA"},{"key":"429_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11248-017-0018-1","volume":"26","author":"J Kristianto","year":"2017","unstructured":"Kristianto J, Johnson MG, Zastrow RK, Radcliff AB, Blank RD (2017) Spontaneous recombinase activity of Cre-ERT2 in vivo. Transgenic Res 26:411\u2013417. https:\/\/doi.org\/10.1007\/s11248-017-0018-1","journal-title":"Transgenic Res"},{"key":"429_CR24","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1371\/journal.pgen.0020146","volume":"2","author":"M Kuraguchi","year":"2006","unstructured":"Kuraguchi M et al (2006) Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet 2:e146. https:\/\/doi.org\/10.1371\/journal.pgen.0020146","journal-title":"PLoS Genet"},{"key":"429_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/520278a","volume":"520","author":"H Ledford","year":"2015","unstructured":"Ledford H (2015) Cancer: the ras renaissance. Nature 520:278\u2013280. https:\/\/doi.org\/10.1038\/520278a","journal-title":"Nature"},{"key":"429_CR26","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1038\/s41598-022-13637-9","volume":"12","author":"S Lenart","year":"2022","unstructured":"Lenart S et al (2022) TACSTD2 upregulation is an early reaction to lung infection. Sci Rep 12:9583. https:\/\/doi.org\/10.1038\/s41598-022-13637-9","journal-title":"Sci Rep"},{"key":"429_CR27","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","volume":"66","author":"A Lievre","year":"2006","unstructured":"Lievre A et al (2006) KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66:3992\u20133995. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0191","journal-title":"Cancer Res"},{"key":"429_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen L et al (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133\u2013140. https:\/\/doi.org\/10.1038\/nn.2467","journal-title":"Nat Neurosci"},{"key":"429_CR29","doi-asserted-by":"publisher","first-page":"12785","DOI":"10.1021\/acs.chemrev.6b00077","volume":"116","author":"G Meinke","year":"2016","unstructured":"Meinke G, Bohm A, Hauber J, Pisabarro MT, Buchholz F (2016) Cre recombinase and other tyrosine recombinases. Chem Rev 116:12785\u201312820. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00077","journal-title":"Chem Rev"},{"key":"429_CR30","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-13-0027","volume":"19","author":"K Ng","year":"2013","unstructured":"Ng K et al (2013) Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens. J Clin Cancer Res 19:3987\u20133995. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0027","journal-title":"J Clin Cancer Res"},{"key":"429_CR31","doi-asserted-by":"publisher","first-page":"1033348","DOI":"10.3389\/fcell.2022.1033348","volume":"10","author":"C Nuevo-Tapioles","year":"2022","unstructured":"Nuevo-Tapioles C, Philips MR (2022) The role of KRAS splice variants in cancer biology. Front Cell Dev Biol 10:1033348. https:\/\/doi.org\/10.3389\/fcell.2022.1033348","journal-title":"Front Cell Dev Biol"},{"key":"429_CR32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.1900642","volume":"251","author":"S O'Gorman","year":"1991","unstructured":"O\u2019Gorman S, Fox DT, Wahl GM (1991) Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251:1351\u20131355. https:\/\/doi.org\/10.1126\/science.1900642","journal-title":"Science"},{"key":"429_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature12796","volume":"503","author":"JM Ostrem","year":"2013","unstructured":"Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM (2013) K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503:548\u2013551. https:\/\/doi.org\/10.1038\/nature12796","journal-title":"Nature"},{"key":"429_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/dvg.20719","volume":"49","author":"V Pospichalova","year":"2011","unstructured":"Pospichalova V et al (2011) Generation of two modified mouse alleles of the Hic1 tumor suppressor gene. Genesis 49:142\u2013151. https:\/\/doi.org\/10.1002\/dvg.20719","journal-title":"Genesis"},{"key":"429_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/dvg.20338","volume":"45","author":"E Provost","year":"2007","unstructured":"Provost E, Rhee J, Leach SD (2007) Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos. Genesis 45:625\u2013629. https:\/\/doi.org\/10.1002\/dvg.20338","journal-title":"Genesis"},{"key":"429_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","volume":"11","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D (2011) RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 11:761\u2013774. https:\/\/doi.org\/10.1038\/nrc3106","journal-title":"Nat Rev Cancer"},{"key":"429_CR37","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1371\/journal.pone.0000162","volume":"2","author":"CS Raymond","year":"2007","unstructured":"Raymond CS, Soriano P (2007) High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2:e162. https:\/\/doi.org\/10.1371\/journal.pone.0000162","journal-title":"PLoS ONE"},{"key":"429_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/75973","volume":"25","author":"CI Rodriguez","year":"2000","unstructured":"Rodriguez CI et al (2000) High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25:139\u2013140. https:\/\/doi.org\/10.1038\/75973","journal-title":"Nat Genet"},{"key":"429_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371:1039\u20131049. https:\/\/doi.org\/10.1056\/NEJMra1404198","journal-title":"N Engl J Med"},{"key":"429_CR40","doi-asserted-by":"publisher","first-page":"14122","DOI":"10.1073\/pnas.0604130103","volume":"103","author":"OJ Sansom","year":"2006","unstructured":"Sansom OJ et al (2006) Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci U S A 103:14122\u201314127. https:\/\/doi.org\/10.1073\/pnas.0604130103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato T et al (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262\u2013265. https:\/\/doi.org\/10.1038\/nature07935","journal-title":"Nature"},{"key":"429_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","volume":"469","author":"T Sato","year":"2011","unstructured":"Sato T et al (2011) Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415\u2013418. https:\/\/doi.org\/10.1038\/nature09637","journal-title":"Nature"},{"key":"429_CR43","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1073\/pnas.85.14.5166","volume":"85","author":"B Sauer","year":"1988","unstructured":"Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 85:5166\u20135170. https:\/\/doi.org\/10.1073\/pnas.85.14.5166","journal-title":"Proc Natl Acad Sci U S A"},{"key":"429_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"429_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nmeth819","volume":"2","author":"NC Shaner","year":"2005","unstructured":"Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905\u2013909. https:\/\/doi.org\/10.1038\/nmeth819","journal-title":"Nat Methods"},{"key":"429_CR46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/gad.1526207","volume":"21","author":"AT Shaw","year":"2007","unstructured":"Shaw AT et al (2007) Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev 21:694\u2013707. https:\/\/doi.org\/10.1101\/gad.1526207","journal-title":"Genes Dev"},{"key":"429_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/embr.201337799","volume":"15","author":"HJ Snippert","year":"2014","unstructured":"Snippert HJ, Schepers AG, van Es JH, Simons BD, Clevers H (2014) Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion. EMBO Rep 15:62\u201369. https:\/\/doi.org\/10.1002\/embr.201337799","journal-title":"EMBO Rep"},{"key":"429_CR48","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/nprot.2015.085","volume":"10","author":"EA Susaki","year":"2015","unstructured":"Susaki EA, Tainaka K, Perrin D, Yukinaga H, Kuno A, Ueda HR (2015) Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging. Nat Protoc 10:1709\u20131727. https:\/\/doi.org\/10.1038\/nprot.2015.085","journal-title":"Nat Protoc"},{"key":"429_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s1535-6108(04)00085-6","volume":"5","author":"DA Tuveson","year":"2004","unstructured":"Tuveson DA et al (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5:375\u2013387. https:\/\/doi.org\/10.1016\/s1535-6108(04)00085-6","journal-title":"Cancer Cell"},{"key":"429_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa2212419","volume":"388","author":"R Yaeger","year":"2023","unstructured":"Yaeger R et al (2023) Adagrasib with or without cetuximab in colorectal cancer with mutated KRAS G12C. N Engl J Med 388:44\u201354. https:\/\/doi.org\/10.1056\/NEJMoa2212419","journal-title":"N Engl J Med"},{"key":"429_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020709","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang H, Huang S, Chu Q (2023) KRAS mutations in solid tumors: characteristics, current therapeutic strategy, and potential treatment exploration. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12020709","journal-title":"J Clin Med"},{"key":"429_CR52","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-10-4563","volume":"71","author":"NP Young","year":"2011","unstructured":"Young NP, Crowley D, Jacks T (2011) Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis. Cancer Res 71:4040\u20134047. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4563","journal-title":"Cancer Res"}],"container-title":["Transgenic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-024-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11248-024-00429-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-024-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:10:09Z","timestamp":1736439009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11248-024-00429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1007\/s11248-024-00429-2","relation":{},"ISSN":["0962-8819","1573-9368"],"issn-type":[{"value":"0962-8819","type":"print"},{"value":"1573-9368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"9"}}